Literature DB >> 26510694

The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.

Samuel S Gidding, Mary Ann Champagne, Sarah D de Ferranti, Joep Defesche, Matthew K Ito, Joshua W Knowles, Brian McCrindle, Frederick Raal, Daniel Rader, Raul D Santos, Maria Lopes-Virella, Gerald F Watts, Anthony S Wierzbicki.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; atherosclerosis; coronary disease; genetic testing; hydroxymethylglutaryl-CoA reductase inhibitors; hyperlipoproteinemia type II; receptors, LDL

Mesh：

Substances：

Year:  2015        PMID： 26510694     DOI： 10.1161/CIR.0000000000000297

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  124 in total

1.  A case of repetitive acute coronary syndrome in a patient with familial hypercholesterolemia.

Authors:  Kota Motozato; Daisuke Sueta; Kenji Sakamoto; Suguru Nagamatsu; Takayoshi Yamashita; Ryota Sato; Tatsuro Mitsuse; Yusuke Kanemaru; Kyoji Takaoka; Koichiro Fujisue; Seiji Takashio; Yuichiro Arima; Eiichiro Yamamoto; Koichi Kaikita; Kenichi Tsujita
Journal:  J Cardiol Cases       Date:  2019-09-14

Review 2.  Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.

Authors:  Krishna G Aragam; Pradeep Natarajan
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.

Authors:  Maya S Safarova; Eric W Klee; Linnea M Baudhuin; Erin M Winkler; Michelle L Kluge; Suzette J Bielinski; Janet E Olson; Iftikhar J Kullo
Journal:  Eur J Hum Genet       Date:  2017-02-01       Impact factor: 4.246

4.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Authors:  Amanda M Perak; Hongyan Ning; Sarah D de Ferranti; Holly C Gooding; John T Wilkins; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

5.  PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

Authors:  Maciej Banach; Piotr Jankowski; Jacek Jóźwiak; Barbara Cybulska; Adam Windak; Tomasz Guzik; Artur Mamcarz; Marlena Broncel; Tomasz Tomasik; Jacek Rysz; Agnieszka Jankowska-Zduńczyk; Piotr Hoffman; Agnieszka Mastalerz-Migas
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

Review 6.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 7.  Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.

Authors:  Bhavin B Adhyaru; Terry A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

8.  Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

Authors:  Leonardo De Luca; Marcello Arca; Pier L Temporelli; Furio Colivicchi; Lucio Gonzini; Donata Lucci; Biagio Bosco; Mariella Callerame; Giulio V Lettica; Andrea Di Lenarda; Michele M Gulizia
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

9.  Effect of Caloric Restriction on Metabolic Dysfunction of Young Rapacz Familial Hypercholesterolemic Swine (Sus scrofa).

Authors:  Nell A Bekiares; Andrea S Chen; Dhanansayan Shanmuganayagam; Adrienne Dardenne Meyers; Thomas D Crenshaw; Christian G Krueger; Jess D Reed
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

Review 10.  Novel Therapies for Familial Hypercholesterolemia.

Authors:  Justin Parizo; Ashish Sarraju; Joshua W Knowles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.